5 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments

3. Gilead Sciences, Inc. (NASDAQ:GILD)

Ariel Investments Stake Value: $172.13 million

Percent of Ariel Investments’ Portfolio: 1.61%

Number of Hedge Fund Holders: 54

Gilead Sciences, Inc. (NASDAQ:GILD) is based in California and operates as drug manufacturer. The company has operations in the US, Europe, and internationally. The company provides drugs for HIV and many other diseases. It has collaboration agreements with companies like Merck and Novo Nordisk.

As of the second quarter of 2021, Ariel Investments holds 2.499 million shares of the company worth $172.14 million. Gilead Sciences, Inc. (NASDAQ:GILD) represents 1.61% of Ariel Investments’ portfolio of 13F securities.

According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 54 have stakes in Gilead Sciences, Inc. (NASDAQ:GILD), worth $1.73 billion. This number has decreased from 65 in the Q1 of 2021, worth $2.68 billion.